Ingevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) P/S ratio
As of 5 November 2026, Ingevity Corporation (NGVT) trades at a P/S ratio of 1.9×. Over the past ten years it has ranged from 0.8× (September 2024) to 4.3× (February 2019); the current reading is higher than 43% of that period. That is above the Specialty Chemicals industry median of 1.6× and above the Basic Materials sector median of 1.6×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.8× | 48.85% |
| FY2024 | 1.2× | 21.72% |
| FY2023 | 1.0× | (37.65%) |
| FY2022 | 1.6× | (20.78%) |
| FY2021 | 2.1× | (20.29%) |
| FY2020 | 2.6× | (8.90%) |
| FY2019 | 2.8× | (8.97%) |
| FY2018 | 3.1× | 1.02% |
| FY2017 | 3.1× | 24.61% |
| FY2016 | 2.5× | 109.57% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 2.2× | 4.69% |
| Mar 2026 | 2.1× | 16.15% |
| Dec 2025 | 1.8× | (3.98%) |
| Sep 2025 | 1.9× | 27.63% |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| STDN Standard Nuclear Inc compare | n/m |
| CC The Chemours Company compare | 0.3× |
| FUL H. B. Fuller Company compare | 0.8× |
| MTX Minerals Technologies Inc. compare | 0.9× |
| IOSP Innospec Inc. compare | 1.0× |
| KWR Quaker Houghton compare | 1.3× |
| NGVT Ingevity Corporation | 1.9× |
| HWKN Hawkins, Inc. compare | 2.8× |
| WDFC WD-40 Company compare | 4.4× |
| Specialty Chemicals industry median | 1.6× |
| Basic Materials sector median | 1.6× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on NGVT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement